Long-Term Toxicity and Survival Outcomes After Stereotactic Ablative Radiotherapy for Patients With Centrally Located Thoracic Tumors: SABR for Central Thoracic Tumors. Radiol Oncol. 2020;54(4):480-487. Accessed October 22, 2026. https://www.radioloncol.com/index.php/ro/article/view/3439